Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Neoplasms × Blood Specimen Collection × Clear all

Phase

Phase NA 37 Phase EARLY_PHASE1 5 Phase 2 4 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Thymic aplasia 1 Small Cell Lung Carcinoma 1 Pain, Postoperative 1 Neoplasms 1 Lung Neoplasms 1 Immunologic Deficiency Syndromes 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Letrozole 16 Docetaxel 11 Anastrozole 11 exemestane 10 Cyclophosphamide 9 Zoledronic Acid 8 Tamoxifen 8 Trastuzumab 7 Paclitaxel 7 Capecitabine 7 pegfilgrastim 6 Saline Solution 6 Fulvestrant 6 liposomal doxorubicin 5 Dexmedetomidine 5 Bupivacaine 5 Bevacizumab 5 Tranexamic Acid 4 Sodium Chloride 4 Filgrastim 4 Epirubicin 4 trastuzumab deruxtecan 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 3 ribociclib 3 pertuzumab 3 palbociclib 3 eribulin 3 abemaciclib 3 Standard of Care 3 Sevoflurane 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06274515 2026-03-09

REMERGE

Hoffmann-La Roche

Phase 4 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡